CME
The Challenge of BCL-2 Resistance in CLL: Treatment Strategies and Emerging Therapies
Host: Thomas Kipps, MD, PhD Determining the optimal treatment regimen for patients with chronic lymphocytic leukemia (CLL) has been a clinical challenge, especially since most patients are older than 70 years, present with significant coexisting